Depreciation in USD of NeuBase Therapeutics, Inc. from 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Depreciation history and change rate from 2010 to Q3 2023.
  • NeuBase Therapeutics, Inc. Depreciation for the quarter ending 30 Sep 2023 was $100,000.000, a 50% decline year-over-year.
  • NeuBase Therapeutics, Inc. Depreciation for the twelve months ending 30 Sep 2023 was $700,000.000, a 12.5% decline year-over-year.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2021 was $400,000.000, a 300% increase from 2020.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2020 was $100,000.000, a 400% increase from 2019.
  • NeuBase Therapeutics, Inc. annual Depreciation for 2019 was $20,000.000, a 95.7% increase from 2018.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

NeuBase Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $700,000 $100,000 -$100,000 -50% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $800,000 $200,000 $0 0% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $800,000 $200,000 $0 0% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023
Q4 2022 $800,000 $200,000 $0 0% 01 Oct 2022 31 Dec 2022 10-QT 05 Jun 2023
Q3 2022 $800,000 $200,000 +$80,000 +66.7% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $720,000 $200,000 +$100,000 +100% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $620,000 $200,000 +$120,000 +1.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $500,000 $200,000 +$100,000 +100% 01 Oct 2021 31 Dec 2021 10-QT 05 Jun 2023
Q3 2021 $400,000 $120,000 +$110,000 +11% 01 Jul 2021 30 Sep 2021 10-K 23 Dec 2021
Q2 2021 $290,000 $100,000 +$70,000 +2.3% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $220,000 $80,000 +$50,000 +1.7% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $170,000 $100,000 +$70,000 +2.3% 01 Oct 2020 31 Dec 2020 10-Q 11 Feb 2022
Q3 2020 $100,000 $10,000 $0 0% 01 Jul 2020 30 Sep 2020 10-K 23 Dec 2021
Q2 2020 $100,000 $30,000 +$20,000 +2% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 $80,000 $30,000 +$30,000 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 $50,000 $30,000 +$30,000 01 Oct 2019 31 Dec 2019 10-Q 11 Feb 2021
Q3 2019 $20,000 $10,000 +$10,000 01 Jul 2019 30 Sep 2019 10-K 23 Dec 2020
Q2 2019 $10,000 $10,000 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $0 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 $0 -$2,867 -100% 01 Oct 2018 31 Dec 2018 10-Q 26 Mar 2020
Q3 2018 $0 28 Aug 2018 30 Sep 2018 10-K 10 Jan 2020
Q4 2017 $2,867 -$12,869 -81.8% 01 Oct 2017 31 Dec 2017 10-Q 14 Feb 2019
Q4 2016 $15,736 +$694 +4.6% 01 Oct 2016 31 Dec 2016 10-Q 14 Feb 2018
Q4 2015 $15,042 +$7,406 +97% 01 Oct 2015 31 Dec 2015 10-Q 14 Feb 2017
Q4 2014 $7,636 +$4,715 +1.6% 01 Oct 2014 31 Dec 2014 10-Q 09 Feb 2016
Q4 2013 $2,921 +$557 +23.6% 01 Oct 2013 31 Dec 2013 10-Q 10 Feb 2015
Q4 2012 $2,364 $0 0% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014
Q4 2011 $2,364 +$1,114 +89.1% 01 Oct 2011 31 Dec 2011 10-Q 19 Feb 2013
Q4 2010 $1,250 01 Oct 2010 31 Dec 2010 10-Q/A 14 Feb 2012

NeuBase Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $400,000 +$300,000 +3% 01 Oct 2020 30 Sep 2021 10-K 23 Dec 2021
2020 $100,000 +$80,000 +4% 01 Oct 2019 30 Sep 2020 10-K 23 Dec 2021
2019 $20,000 +$9,780 +95.7% 01 Oct 2018 30 Sep 2019 10-K 23 Dec 2020
2018 $10,220 -$34,852 -77.3% 01 Oct 2017 30 Sep 2018 10-K 03 Jan 2019
2017 $45,072 -$19,560 -30.3% 01 Oct 2016 30 Sep 2017 10-K 03 Jan 2019
2016 $64,632 +$24,009 +59.1% 01 Oct 2015 30 Sep 2016 10-K 15 Dec 2017
2015 $40,623 +$22,773 +1.3% 01 Oct 2014 30 Sep 2015 10-K 22 Dec 2016
2014 $17,850 +$4,494 +33.6% 01 Oct 2013 30 Sep 2014 10-K 22 Dec 2016
2013 $13,356 +$3,900 +41.2% 01 Oct 2012 30 Sep 2013 10-K 14 Dec 2015
2012 $9,456 +$4,452 +89% 01 Oct 2011 30 Sep 2012 10-K 22 Dec 2014
2011 $5,004 +$4,154 +4.9% 01 Oct 2010 30 Sep 2011 10-K 09 Jan 2013
2010 $850 01 Oct 2009 30 Sep 2010 10-K/A 18 Jan 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.